Navigating the regulatory challenge of PFAS for pharmaceutical manufacturers
European Pharmaceutical Review
APRIL 10, 2025
In the EU, a joint PFAS Restriction Proposal under REACH was submitted, aiming for a full ban by 2028/2030. This poses a significant challenge for pharmaceutical manufacturers, not least because of the technical challenges related to operations, supply chain and the environment. There is worldwide concern around the use of PFAS.
Let's personalize your content